SCIENTURE expands Arbli™ payor coverage

SCIENTURE has significantly expanded the payor coverage and commercial access for its product, Arbli™. This expansion adds approximately 12.5 million covered lives nationwide, enhancing pharmacy access and channel reach. The move is strategically designed to drive increased prescription volume and revenue growth for Arbli™. This broader market penetration positions SCIENTURE for substantial commercial success and reinforces its commitment to improving patient access to its therapies.